Evidence map›Paper›PMID 41995027›Full record

ArticleJournal of cell science2026

GAK antagonises ROCK-dependent regulation of actomyosin dynamics.

Masaki Hiramoto, Naoharu Takano, Hiroko Kokuba, Hiromi Kazama, Hirotsugu Hino, Hiroshi Handa, Keisuke Miyazawa

Abstract read
In one paragraph

Article in Journal of cell science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Masaki HiramotoDepartment of Biochemistry, Tokyo Medical University, Tokyo 160-8402, Japan.ORCID 0000-0002-1076-6515
Naoharu TakanoDepartment of Biochemistry, Tokyo Medical University, Tokyo 160-8402, Japan.
Hiroko KokubaLaboratory of Electron Microscopy, Institute of Medical Science, Tokyo Medical University, Tokyo 160-8402, Japan.
Hiromi KazamaDepartment of Biochemistry, Tokyo Medical University, Tokyo 160-8402, Japan.
Hirotsugu HinoDepartment of Biochemistry, Tokyo Medical University, Tokyo 160-8402, Japan.
Hiroshi HandaMolecular Pharmacology Division, Institute of Medical Science, Tokyo Medical University, Tokyo 160-8402, Japan.
Keisuke MiyazawaDepartment of Biochemistry, Tokyo Medical University, Tokyo 160-8402, Japan.

Funding

Japan Society for the Promotion of Science 18K06901Japan Society for the Promotion of Science 21K07106Japan Society for the Promotion of Science 25K11442Ministry of Education, Culture, Sports, Science and Technology S1411011Tokyo Medical University
6 · The paper itself

Abstract

Cytoskeletal proteins, such as actin and myosin, are essential for regulating cell morphology and motility. Rho-associated kinase (ROCK; herein referring collectively to ROCK1 and ROCK2) is a key regulator of actomyosin dynamics, including stress fibre formation and cell migration. Our previous study revealed that cyclin G-associated kinase (GAK) antagonises ROCK signalling during autophagic flux regulation; however, the underlying molecular mechanisms remained unclear. In this study, we investigated the role of GAK in cytoskeletal dynamics and cell motility by genetically disrupting GAK. GAK-knockout cells exhibited enhanced stress fibre formation and cell migration, accompanied by increased phosphorylation of myosin light chain (MLC). Notably, the inhibition of stress fibre formation and MLC phosphorylation was more dependent on the intrinsically disordered region (IDR) of GAK than on its kinase activity. GAK IDR interacted with ARHGEF2, and ARHGEF2 knockdown suppressed stress fibre formation in GAK-knockout cells. Furthermore, the GAK IDR contributes to the regulation of MLC expression. Together, these findings indicate that GAK IDR is a crucial regulator of actomyosin dynamics and cell motility, and suggest that GAK antagonises ROCK-dependent cytoskeletal regulation through the coordinated control of ARHGEF2 activity and MLC expression.

Indexed as

ActomyosinProtein Serine-Threonine Kinasesrho-Associated KinasesAnimalsCell MovementHumansMyosin Light ChainsPhosphorylationRho Guanine Nucleotide Exchange FactorsSignal TransductionStress FibersActomyosinMyosin Light ChainsProtein Serine-Threonine Kinasesrho-Associated KinasesRho Guanine Nucleotide Exchange FactorsActomyosinARHGEF2Cell migrationGAKROCKStress fibre

Identifiers

PMID41995027
PMCPMC13120681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.